InvestorsHub Logo
icon url

tredenwater2

06/21/24 1:18 PM

#461970 RE: falconer66a #461963

Good points falconner. We have recently seen what a company with an approved Schizophrenia drug is worth, north of 12 billion, but what we havent seen yetis what a 100 million OS company with a safe and efficacious Alzheimers drug is worth with a EMA approval and USA approval. Its all forming together quite nicely and time is our biggest enemy. The longer it takes the more Institutional investment absorbs shares at depressed prices. Dr. Missling has been steady as a rock with his eye on the approval prize. From the Fda’s relaxed endpoint on AD, the EMA “pulling us into submitting”, to other companies on ALL disease fronts either crashing and burning or just flat out patients and groups rebuking them.

Things that make you go hmmmmm.